These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23770559)

  • 1. Gastrointestinal bleeding secondary to interaction of Artemisia absinthium with warfarin.
    Açıkgöz SK; Açıkgöz E
    Drug Metabol Drug Interact; 2013; 28(3):187-9. PubMed ID: 23770559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probable interaction between Lycium barbarum (goji) and warfarin.
    Rivera CA; Ferro CL; Bursua AJ; Gerber BS
    Pharmacotherapy; 2012 Mar; 32(3):e50-3. PubMed ID: 22392461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between warfarin and cranberry juice.
    Paeng CH; Sprague M; Jackevicius CA
    Clin Ther; 2007 Aug; 29(8):1730-5. PubMed ID: 17919554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin and royal jelly interaction.
    Lee NJ; Fermo JD
    Pharmacotherapy; 2006 Apr; 26(4):583-6. PubMed ID: 16553520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-ingestion of herbal medicines and warfarin.
    Smith L; Ernst E; PaulEwings ; Myers P; Smith C
    Br J Gen Pract; 2004 Jun; 54(503):439-41. PubMed ID: 15186565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginseng and other herbal medicines that interact with warfarin.
    Cheng TO
    Int J Cardiol; 2005 Sep; 104(2):227. PubMed ID: 16168817
    [No Abstract]   [Full Text] [Related]  

  • 8. Leflunomide and warfarin interaction: case report and review of the literature.
    Chonlahan J; Halloran MA; Hammonds A
    Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation.
    Chan HT; So LT; Li SW; Siu CW; Lau CP; Tse HF
    J Cardiovasc Pharmacol; 2011 Jul; 58(1):87-90. PubMed ID: 21558883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan potentiation of warfarin effect.
    Huang SS; Sung SH; Chiang CE
    Ann Pharmacother; 2007 Nov; 41(11):1912-4. PubMed ID: 17925502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledges about herbal products among subjects on warfarin therapy and patient-physician relationship: a pilot study.
    Cuzzolin L; Francini-Pesenti F; Zaffani S; Brocadello F; Pengo V; Bassi A; Benoni G
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1014-7. PubMed ID: 17615601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
    Shah HR; Ledbetter L; Diasio R; Saif MW
    Clin Colorectal Cancer; 2006 Jan; 5(5):354-8. PubMed ID: 16512995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation.
    Howard PA; Ellerbeck EF; Engelman KK; Patterson KL
    Pharmacoepidemiol Drug Saf; 2002; 11(7):569-76. PubMed ID: 12462133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.
    Blackshear JL; Baker VS; Holland A; Litin SC; Ahlquist DA; Hart RG; Ellefson R; Koehler J
    Arch Intern Med; 1996 Mar; 156(6):658-60. PubMed ID: 8629878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Warfarin treatment and bleeding].
    Breen AB; Vaskinn TE; Reikvam A; Skovlund E; Lislevand H; Madsen S
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1835-7. PubMed ID: 12830257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interactions between warfarin and natural products].
    Solhaug V; Nergård CS
    Tidsskr Nor Laegeforen; 2010 Jun; 130(12):1252-4. PubMed ID: 20567279
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical workload, risk factors and complications in patients on warfarin with gastrointestinal bleeding.
    Som R; Gossage JA; Crane A; Rowe PH
    Int J Surg; 2010; 8(1):52-5. PubMed ID: 19883802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction.
    Howard-Thompson A; Hurdle AC; Arnold LB; Finch CK; Sands C; Self TH
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):33-6. PubMed ID: 18396247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.